SPOTLIGHT -
Prescription Digital Therapeutic for Schizophrenia Receives FDA Breakthrough Device Designation
The device is currently under clinical trial investigation as an adjunct treatment to standard of care therapy for experiential negative symptoms of schizophrenia.
Psychiatry in the News: December 2023
Here are some updates from the world of psychiatry throughout the month of December.
Seasonal Affective Disorder Research Roundup: December 29, 2023
What is new in research on seasonal affective disorder?
From the Pages of Psychiatric Times: December 2023
The experts weighed in on a wide variety of psychiatric issues for the December 2023 issue of Psychiatric Times.
The Year in Cover Stories 2023
Here are highlights from some of the year’s top features in Psychiatric Times from throughout 2023.
Continuing Medical Education 2023
Reviewing a year of CMEs in Psychiatric Times®
The Week in Review: December 18-22
From new guidelines for the utilization of artificial intelligence in health care to the efficacy of fish oil as a replacement for antidepressants, here are highlights from the week in Psychiatric Times.
Schizophrenia Research Roundup: December 22, 2023
What is new in research on schizophrenia?
Insights and Highlights From the Annual Psychiatric Times World CME Conference
Did you miss the 2023 Annual Psychiatric Times World CME Conference? Don't worry, we've got you covered.
The Week in Review: December 11-15
From a new look at the famous STAR*D study to updates from the National Academy of Sciences Conference on Adult ADHD, here are highlights from the week in Psychiatric Times.
ADHD Research Roundup: December 15, 2023
What is new in research on ADHD?
Positive Topline Results Announced for Phase 2b Clinical Trial of GAD Treatment
“This is the first study to assess the standalone drug effects of MM-120 in the absence of any psychotherapeutic intervention.”
The Week in Review: December 4-8
From adjunctive cariprazine for the treatment of major depressive disorder to a new app for prescribing antidepressants and antipsychotics, here are highlights from the week in Psychiatric Times.
Cannabis Research Roundup: December 8, 2023
What is new in research on cannabis?
The Week in Review: November 27-December 1
From dopamine detoxification for problem gaming to connections between bacteria and anxiety and depression, here are highlights from the week in Psychiatric Times.
Bipolar Disorder Research Roundup: December 1, 2023
What is new in research on bipolar disorder?
Research Explores Connection Between Bacteria and Depression, Anxiety
The results suggest that the bacterium Lactobacillus may aid in the management of stress and in the prevention of these disorders.
From the Pages of Psychiatric Times: November 2023
The experts weighed in on a wide variety of psychiatric issues for the November 2023 issue of Psychiatric Times.
Psychiatry in the News: November 2023
Here are some updates from the world of psychiatry throughout the month of November.
FDA Accepts NDA, Grants PDUFA Date for Investigational Schizophrenia Treatment
The FDA’s decision is set for September 2024.
The Week in Review: November 20-24
From late-life treatment-resistant depression to the mental health benefits of gratitude, here are highlights from the week in Psychiatric Times.
Anxiety Research Roundup: November 24, 2023
What is new in research on anxiety symptoms and disorders?
Celebrating Thanksgiving 2023
Psychiatric Times revisits some meaningful reflections on Thanksgiving, family traditions, and the value of gratitude and thankfulness.
The Week in Review: November 13-17
From sleep disturbances in ADHD to psychotherapy for treatment-resistant depression, here are highlights from the week in Psychiatric Times.
Psychedelics Research Roundup: November 17, 2023
What is new in research on psychedelics?
The Week in Review: November 6-10
From neurological abnormalities in first-episode psychosis to psychiatric boarding in emergency departments, here are highlights from the week in Psychiatric Times.
Dementia Research Roundup: November 10, 2023
What is new in research on dementia?
Study Finds That Long-Acting Schizophrenia Treatment Prolongs Time to Impending Relapse
These results were instrumental in securing the FDA approval of the drug for the treatment of schizophrenia in adults in April 2023.
The Week in Review: October 30-November 3
From sleep and neuroendocrine function following TBI to new phase 3 results from a clinical trial evaluating a promising new schizophrenia treatment, here are highlights from the week in Psychiatric Times.
Substance Use Disorders Research Roundup: November 3, 2023
What is new in research on SUDs?